UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 30, 2007
COLGATE-PALMOLIVE COMPANY
(Exact name of registrant as specified in its charter)
| Delaware | 1-644-2 | 13-1815595 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
| 300 Park Avenue, New York, NY | 10022 | |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 2.02. | Results of Operations and Financial Condition. |
On October 30, 2007, Colgate-Palmolive Company issued a press release announcing its earnings for the quarter ended September 30, 2007. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
| Item 9.01. | Financial Statements and Exhibits. |
| (d) | Exhibits. The following exhibit is filed with this document: |
| Exhibit Number |
Description | |
| 99 | Press release, dated October 30, 2007, issued by Colgate-Palmolive Company |
2
EXHIBIT INDEX
| Exhibit |
Description | |
| 99 |
Press release, dated October 30, 2007, issued by Colgate-Palmolive Company |
3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| COLGATE-PALMOLIVE COMPANY | ||||||
| Date: October 30, 2007 |
By: | /s/ STEPHEN C. PATRICK | ||||
| Name: | Stephen C. Patrick | |||||
| Title: | Chief Financial Officer | |||||
4
Exhibit 99
Bina Thompson 212-310-3072
Hope Spiller 212-310-2291
FOR IMMEDIATE RELEASE…
Colgate Announces Strong 3rd Quarter, Exceeding Expectations
Operating and Net Profit Up Double-Digit
Excellent Sales and Volume Growth Worldwide
New York, New York, October 30, 2007… Colgate-Palmolive Company (NYSE:CL) today announced excellent worldwide sales and unit volume growth together with double-digit earnings growth for third quarter 2007. Worldwide sales grew 12.0% to $3,528.2 million and unit volume grew 5.5%, as reported. Excluding divestments, worldwide sales and unit volume grew 13.0% and 6.5%, respectively. Global pricing increased 1.0%, and foreign exchange added 5.5%. The very strong top-line growth was supported by a 12% increase in worldwide advertising spending.
Third quarter 2007 results include $36.3 million of aftertax charges related to the 2004 Restructuring Program and a $10.0 million non-cash, aftertax SFAS 88 pension charge with no such comparable pension charge in 2006. This SFAS 88 pension charge is a result of lump sum payments of normal retirement benefits associated with a nonqualified retirement plan in the United States. In the year ago quarter, restructuring charges were $58.5 million aftertax.
As reported, gross profit margin increased 120 basis points to 56.2%. Excluding restructuring charges, gross profit margin increased 80 basis points to a record 57.3% on top of the 140 basis point improvement in the year ago period, despite significant increases in agricultural commodity costs in the Hill’s division.
Operating profit as reported increased 22% versus third quarter 2006 to $668.8 million, 19.0% of sales. Excluding restructuring and SFAS 88 charges, operating profit rose 16%
to $735.3 million. On the same basis, operating profit margin was 20.8% of sales, up 70 basis points versus the year ago period.
Reported net income and diluted earnings per share in third quarter 2007 were $420.1 million and $.77, respectively. Excluding restructuring and SFAS 88 charges, net income in the quarter increased 16% versus third quarter 2006 to a record $466.4 million, and diluted earnings per share increased 18% to $.86, also a record. In third quarter 2006, reported net income and diluted earnings per share were $344.1 million and $.63, respectively, and net income and diluted earnings per share excluding restructuring charges were $402.6 million and $.73, respectively.
Net cash provided by operations year to date increased by 20% to $1,638.7 million after building inventories to support the business during factory closings related to the 2004 Restructuring Program. Colgate’s strong balance sheet strengthened even further during the period with key measures improving and net debt declining versus third quarter 2006 and second quarter 2007. End of third quarter 2007 working capital improved to 2.4% of sales versus 2.6% in the comparable 2006 period.
Ian Cook, President and CEO commented, “We are delighted that our excellent top and bottom line growth momentum continued this quarter with every geographic region delivering sales and profit increases. This is the fourth consecutive quarter of double-digit sales and profit growth worldwide, and our 18% increase in earnings per share, excluding restructuring and SFAS 88 charges, is the highest quarterly increase we have seen in over four years.
“Colgate’s market shares are strong and getting stronger in key markets around the world. Colgate strengthened its global leadership in toothpaste and manual toothbrushes during the quarter and our global market share in both categories increased to all-time record highs.
2
“The gross margin expansion and other savings programs helped fund higher advertising spending across all operating divisions while still generating double-digit operating profit growth worldwide.
“We are of course pleased that the excellent operating profitability delivered higher than expected net income and earnings per share even after the significant increase in advertising spending and absorbing a higher than expected tax rate in the quarter.”
Mr. Cook further commented, “As we look to the balance of the year we are confident that the strong top-line growth will continue, driven by our very full new product pipeline with an array of impactful, integrated marketing campaigns to support them. We expect gross profit margin, excluding restructuring charges, to be up within our targeted range of 75 to 125 basis points for this year and next year as well, as a result of our ongoing cost-savings initiatives, the benefits from restructuring, efficiencies in promotional programs and a continued shift towards higher-margin products.
“All this adds to our strong confidence that we will deliver double-digit earnings per share growth for the balance of 2007 and full year 2008.”
At 11:00 a.m. ET today, Colgate will host a conference call to elaborate on third quarter results. To access this call as a webcast, please go to Colgate’s web site at http://www.colgate.com.
The following are comments about divisional performance. See attached Geographic Sales Analysis and Segment Information schedules for additional information on divisional sales and operating profit.
North America (20% of Company Sales)
Positive growth continued in North America, fueled by new product sales and market share gains. As reported, sales and unit volume grew 3.0% and 1.5%, respectively. Excluding the divestiture of the Canadian household bleach business, sales and unit volume grew 4.5% and 3.0%, respectively. Pricing increased 0.5% and foreign exchange
3
added 1.0%. North American operating profit increased 19% during the quarter to an all-time record level.
In the U.S., new product launches in the super-premium category are contributing to growth in oral care. Colgate Total Advanced Clean toothpaste, supported by an integrated marketing campaign featuring Brooke Shields and an expansive professional sampling program, helped drive market share for Colgate Total toothpaste to its highest quarterly share ever at 15.3%. Colgate Max Fresh BURST toothpaste, infused with 50% more mini breath strips, continues to build incremental market share for the Max Fresh equity, now at 3.9% year to date. Colgate’s share of the manual toothbrush market is 25.6% year to date, up 2.0 share points versus year ago, fueled by the continued success of Colgate 360° manual toothbrush and its latest variant Colgate 360° Sensitive.
Positive growth momentum for both sales and profits in North America is expected to continue. Successful new products contributing to growth in other categories include Irish Spring body wash for men, Softsoap brand Nutra-Oil moisturizing body wash and Mennen Speed Stick 24/7 Gametime deodorant. Fabuloso liquid cleaner, Suavitel fabric conditioner and Irish Spring bar soap each achieved record high market shares year to date.
New products planned for launch in the fourth quarter include Softsoap brand SPA Radiant body wash and liquid hand soap, Irish Spring Moisture Blast and Irish Spring Reviving Mint body washes, Softsoap brand Pink Grapefruit liquid hand soap and Mennen Speed Stick 24/7 Momentum deodorant.
Latin America (25% of Company Sales)
As reported, Latin American sales and unit volume grew 16.0% and 7.5%, respectively, in the third quarter. Excluding the divested bleach businesses, sales and unit volume grew 18.0% and 9.5%, respectively. All significant markets in the region contributed to the very strong volume gains, led by Mexico, Brazil, Venezuela, Central America, Argentina and Ecuador. Higher pricing added 3.0% and foreign exchange added 5.5%.
4
Latin American operating profit increased 13%, to an all-time record level even after a strong double-digit increase in advertising during the quarter.
Colgate continues to build its strong leadership in oral care throughout Latin America with its regional toothpaste market share at a record high year to date driven by market share gains in nearly every country. The multi-country rollout of Colgate Total Professional Clean toothpaste helped drive the regional market share for Colgate Total to an all-time high during the quarter. Colgate Max Fresh and Colgate Max White toothpastes also achieved share gains year to date. Colgate’s leading share of the manual toothbrush market for the region is at a record high year to date, up 320 basis points versus year ago. Strong sales of Colgate 360° manual toothbrush throughout the region contributed to this success.
In other product categories, Plax Alcohol Free and Plax Ice mouthwashes, Palmolive Naturals Mint & Eucalyptus, Palmolive Nutri-Milk, Protex Deo 12 and Protex Propolis bar soaps, Lady Speed Stick Double Defense deodorant, Palmolive Caprice shampoo and Palmolive Nutri-Milk shower gel contributed to market share gains in the region.
Europe/South Pacific (25% of Company Sales)
Europe/South Pacific sales increased 12.0% to a record level, and unit volume grew 4.5%. Pricing was negative 2.0% and foreign exchange added 9.5%. Strong volume gains in the Gaba business, the United Kingdom, Denmark and Romania more than offset a volume decline in Germany due to challenging market conditions. Operating profit for the region grew 11% to an all-time record level, even after a significant increase in advertising during the quarter.
Colgate increased its oral care leadership in Europe/South Pacific led by toothpaste market share gains in France, Germany, United Kingdom, Italy, Spain, Greece, Austria, Norway, Romania, Denmark, Belgium, Poland and Australia. Successful premium products driving these share gains include Colgate Total, Colgate Total Professional Weekly Clean and Colgate Max Fresh toothpastes. Gaba’s toothpaste market share also grew in many markets across the region, in both the food and pharmacy channels. In the
5
manual toothbrush category, strong sales of Colgate 360°, Colgate 360° Sensitive and Colgate Max Fresh toothbrushes strengthened Colgate’s market leadership in this category for the region.
Recent premium innovations contributing to gains in other product categories include Palmolive Pure Cashmere shower gel, Colgate Plax Gentle Care mouth rinse, Soupline Aromatherapy fabric conditioner, and Ajax Professional bucket dilutable and Ajax Professional glass cleaners.
Greater Asia/Africa (17% of Company Sales)
Greater Asia/Africa sales and unit volume increased 18.5% and 9.5%, respectively. The strong volume gains were led by India, Russia, Turkey, Ukraine, South Africa, the Gulf States and the Greater China region, where volume increased 17% during the quarter. For the division as a whole, pricing increased 1.0% and foreign exchange added 8.0%. Operating profit for the region increased 38% to an all-time record level, even after a sizable increase in advertising spending during the quarter.
Colgate strengthened its oral care leadership in the Greater Asia region with 11 out of 14 countries reporting toothpaste market share gains versus year ago led by India, China, Philippines, Thailand, Ukraine, Russia and the rest of the CIS countries. Colgate’s share of the manual toothbrush market also strengthened throughout the region with many countries achieving record high shares in the category. Successful new products driving the oral care growth include Colgate Total Professional Clean, Colgate Herbal Seabuckthorn, Darlie Double Action and Colgate Max White toothpastes, and Colgate 360°, Colgate 360° Sensitive and Colgate Twister Fresh manual toothbrushes.
New products contributing to growth in other categories in the region include Palmolive Thermal Spa Seabuckthorn shower gel, bar soap and liquid hand soap, Palmolive Pure Cashmere shower cream and bar soap, and Palmolive Floral and Odor Neutralizing liquid hand soap.
6
Hill’s (13% of Company Sales)
Innovative new products and veterinary recommendations continue to drive growth at Hill’s, a world leader in specialty pet food. Hill’s sales and unit volume grew 12.0% and 5.0%, respectively, during the quarter. Pricing increased 4.0% and foreign exchange added 3.0%. Operating profit increased 10% even after significantly higher agricultural commodity costs during the quarter.
Consumption growth and market share gains in the U.S. specialty pet channel during the quarter were driven by strong sales of Science Diet Canine Large Breed and Science Diet Canine Lamb & Rice Small Bites. The relaunch of Science Diet Canine Nature’s Best with upgraded all natural ingredients during the quarter is also off to a strong start. Science Diet Indoor Cat and Science Diet Light contributed to growth in feline. Prescription Diet c/d Multicare Feline, a therapeutic food for the nutritional management of cats with feline lower urinary tract disease, Prescription Diet d/d Canine and Prescription Diet j/d Canine drove growth in the U.S. veterinary channel.
Internationally, growth was strong led by Russia, South Africa, the United Kingdom, Italy, Spain, Germany, Australia and France. New pet food products contributing to the international growth include Prescription Diet j/d Canine and Feline, Science Plan Feline Chunks in Gravy pouches and Science Plan Neutered Cat, a veterinary exclusive product.
* * *
About Colgate-Palmolive: Colgate-Palmolive is a leading global consumer products company, tightly focused on Oral Care, Personal Care, Home Care and Pet Nutrition. Colgate sells its products in over 200 countries and territories around the world under such internationally recognized brand names as Colgate, Palmolive, Mennen, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, Elmex, Tom’s of Maine, Ajax, Axion, Soupline, and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet. For more information about Colgate’s global business, visit the Company’s web site at http://www.colgate.com.
7
Unless otherwise indicated, all market share data included in this press release is as measured by ACNielsen.
This press release and the related webcast (other than historical information) may contain forward-looking statements. Such statements may relate, for example, to sales or volume growth, profit growth, earnings growth, financial goals, cost-reduction plans, estimated charges and savings associated with the 2004 Restructuring Program and new product introductions. These statements are made on the basis of our views and assumptions as of this time and we undertake no obligation to update these statements. We caution investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. Investors should consult the Company’s filings with the Securities and Exchange Commission (including the information set forth under the captions “Risk Factors” and “Cautionary Statement on Forward-Looking Statements” in the Company’s Form 10-K for the year ended December 31, 2006) for information about certain factors that could cause such differences. Copies of these filings may be obtained upon request from the Company’s Investor Relations Department or the Company’s web site at http://www.colgate.com.
Non-GAAP Financial Measures
The following provides information regarding the non-GAAP measures used in this earnings release:
To supplement Colgate’s condensed consolidated financial statements presented in accordance with accounting principles generally accepted in the United States of America (GAAP), the Company has disclosed non-GAAP measures of operating results that exclude certain items. Net sales, cost of sales, gross profit margin, selling, general and administrative expenses, operating profit, operating profit margin, other (income) expense, the provision for income taxes and effective tax rate, net income, and earnings per share are discussed in this release both as reported (on a GAAP basis) and excluding the impact of certain items reported in the corporate segment, as explained below:
8
| • | The restructuring charges relate to the restructuring program that began in the fourth quarter of 2004 and is expected to be substantially completed by 2008 (the “2004 Restructuring Program”). These restructuring charges include separation-related costs, incremental depreciation and asset write-downs, and other costs related to the implementation of the 2004 Restructuring Program. In light of their nature and magnitude, the Company believes these items should be presented separately to enhance an investor’s overall understanding of its ongoing operations. |
| • | The four Other Items, which pertained to the nine months ended September 30, 2007, are comprised of the gain on sale of the Company’s household bleach business in Latin America, a charge related to the limited voluntary product recall of certain Hill’s feline products, tax adjustments which consist of the reduction of a tax loss carryforward valuation allowance in Brazil, partially offset by tax provisions for the recapitalization of certain overseas subsidiaries, all of which occurred in the first quarter of 2007, and a third quarter 2007 charge associated with certain pension obligations in accordance with Statement of Financial Accounting Standards (SFAS) No. 88, “Employers’ Accounting for Settlement and Curtailments of Defined Benefit Pension Plans and for Termination Benefits” ( “SFAS 88 charge”). The amount of each such excluded item for the three and nine months ended September 30, 2007 is set forth in the table entitled “Supplemental Consolidated Income Statement Information – Other Items” included with this release. In light of their nature and magnitude, the Company believes that these four Other Items should be presented separately to enhance an investor’s overall understanding of its ongoing operations. |
Management believes these non-GAAP financial measures provide useful information to investors regarding the underlying business trends and performance of the Company’s ongoing operations and are useful for period over period comparisons of such operations. The Company uses these financial measures internally in its budgeting process and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company’s business, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a
9
substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies. See “Consolidated Income Statement and Supplemental Information—Reconciliation Excluding the 2004 Restructuring Program and Other Items” for the three and nine months ended September 30, 2007 and 2006 included with this release for a reconciliation of these financial measures to the related GAAP measures.
Sales and unit volume growth, both worldwide and in relevant geographic divisions, and operating profit in certain geographic divisions are discussed in this release both as reported and excluding divestments. Management believes this provides useful information to investors as it allows comparisons of sales growth and volume growth and operating profit from ongoing operations. See “Geographic Sales Analysis, Percentage Changes—Third Quarter 2007 vs. 2006” for a comparison of sales excluding divestments to sales as reported in accordance with GAAP.
The Company defines free cash flow before dividends as net cash provided by operations less capital expenditures. As management uses this measure to evaluate the Company’s ability to satisfy current and future obligations, repurchase stock, pay dividends and fund future business opportunities, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. Free cash flow before dividends is not a GAAP measurement and may not be comparable to similarly titled measures reported by other companies.
(See attached tables for third quarter results.)
10
Table 1
Colgate-Palmolive Company
Consolidated Income Statement and Supplemental Information
Reconciliation Excluding the 2004 Restructuring Program and Other Items
For the Three Months Ended September 30, 2007 and 2006
(in Millions Except Per Share Amounts) (Unaudited)
| 2007 | 2006 | |||||||||||||||||||||||||||
| As Reported | Restructuring | Other Items (a) | Excluding Restructuring & Other Items |
As Reported | Restructuring | Excluding Restructuring |
||||||||||||||||||||||
| Net sales |
$ | 3,528.2 | $ | — | $ | — | $ | 3,528.2 | $ | 3,143.7 | $ | — | $ | 3,143.7 | ||||||||||||||
| Cost of sales |
1,544.6 | 37.4 | — | 1,507.2 | 1,415.3 | 47.0 | 1,368.3 | |||||||||||||||||||||
| Gross profit |
1,983.6 | (37.4 | ) | — | 2,021.0 | 1,728.4 | (47.0 | ) | 1,775.4 | |||||||||||||||||||
| Gross profit margin |
56.2 | % | 57.3 | % | 55.0 | % | 56.5 | % | ||||||||||||||||||||
| Selling, general and administrative expenses |
1,277.7 | 11.8 | — | 1,265.9 | 1,140.3 | 11.5 | 1,128.8 | |||||||||||||||||||||
| Other (income) expense, net |
37.1 | 1.9 | 15.4 | 19.8 | 38.7 | 25.5 | 13.2 | |||||||||||||||||||||
| Operating profit |
668.8 | (51.1 | ) | (15.4 | ) | 735.3 | 549.4 | (84.0 | ) | 633.4 | ||||||||||||||||||
| Operating profit margin |
19.0 | % | 20.8 | % | 17.5 | % | 20.1 | % | ||||||||||||||||||||
| Interest expense, net |
38.5 | — | — | 38.5 | 41.2 | — | 41.2 | |||||||||||||||||||||
| Income before income taxes |
630.3 | (51.1 | ) | (15.4 | ) | 696.8 | 508.2 | (84.0 | ) | 592.2 | ||||||||||||||||||
| Provision for income taxes |
210.2 | (14.8 | ) | (5.4 | ) | 230.4 | 164.1 | (25.5 | ) | 189.6 | ||||||||||||||||||
| Effective tax rate |
33.3 | % | 33.1 | % | 32.3 | % | 32.0 | % | ||||||||||||||||||||
| Net income |
420.1 | (36.3 | ) | (10.0 | ) | 466.4 | 344.1 | (58.5 | ) | 402.6 | ||||||||||||||||||
| Earnings per common share |
||||||||||||||||||||||||||||
| Basic |
$ | 0.81 | $ | (0.07 | ) | $ | (0.02 | ) | $ | 0.90 | $ | 0.65 | $ | (0.12 | ) | $ | 0.77 | |||||||||||
| Diluted |
$ | 0.77 | $ | (0.07 | ) | $ | (0.02 | ) | $ | 0.86 | $ | 0.63 | $ | (0.10 | ) | $ | 0.73 | |||||||||||
| Average common shares outstanding |
||||||||||||||||||||||||||||
| Basic |
509.9 | 509.9 | 509.9 | 509.9 | 515.3 | 515.3 | 515.3 | |||||||||||||||||||||
| Diluted |
542.4 | 542.4 | 542.4 | 542.4 | 550.4 | 550.4 | 550.4 | |||||||||||||||||||||
| (a) | See Table 3 “Supplemental Consolidated Income Statement Information - Other Items” for details. |
| Note: | Basic and diluted earnings per share for the “As Reported” and “Excluding Restructuring & Other Items” are computed independently for each quarter and the nine months presented. As a result of changes in shares outstanding during the year and rounding, the sum of the three quarters' earnings per share may not necessarily equal the earnings per share for the nine months. In addition, the impact of “Restructuring” and “Other Items” in 2007 on the basic and diluted earnings per share may not necessarily equal the earnings per share if calculated independently as a result of rounding. |
Table 2
Colgate-Palmolive Company
Consolidated Income Statement and Supplemental Information
Reconciliation Excluding the 2004 Restructuring Program and Other Items
For the Nine Months Ended September 30, 2007 and 2006
(in Millions Except Per Share Amounts) (Unaudited)
| 2007 | 2006 | |||||||||||||||||||||||||||
| As Reported | Restructuring | Other Items (a) | Excluding Restructuring & Other Items |
As Reported | Restructuring | Excluding Restructuring |
||||||||||||||||||||||
| Net sales |
$ | 10,147.5 | $ | — | $ | (2.1 | ) | $ | 10,149.6 | $ | 9,028.6 | $ | — | $ | 9,028.6 | |||||||||||||
| Cost of sales |
4,443.3 | 103.8 | (1.1 | ) | 4,340.6 | 4,103.6 | 156.8 | 3,946.8 | ||||||||||||||||||||
| Gross profit |
5,704.2 | (103.8 | ) | (1.0 | ) | 5,809.0 | 4,925.0 | (156.8 | ) | 5,081.8 | ||||||||||||||||||
| Gross profit margin |
56.2 | % | 57.2 | % | 54.5 | % | 56.3 | % | ||||||||||||||||||||
| Selling, general and administrative expenses |
3,671.6 | 32.9 | — | 3,638.7 | 3,210.2 | 30.6 | 3,179.6 | |||||||||||||||||||||
| Other (income) expense, net |
55.1 | 15.7 | (20.6 | ) | 60.0 | 187.0 | 130.3 | 56.7 | ||||||||||||||||||||
| Operating profit |
1,977.5 | (152.4 | ) | 19.6 | 2,110.3 | 1,527.8 | (317.7 | ) | 1,845.5 | |||||||||||||||||||
| Operating profit margin |
19.5 | % | 20.8 | % | 16.9 | % | 20.4 | % | ||||||||||||||||||||
| Interest expense, net |
121.6 | — | — | 121.6 | 119.8 | — | 119.8 | |||||||||||||||||||||
| Income before income taxes |
1,855.9 | (152.4 | ) | 19.6 | 1,988.7 | 1,408.0 | (317.7 | ) | 1,725.7 | |||||||||||||||||||
| Provision for income taxes |
533.4 | (44.5 | ) | (65.8 | ) | 643.7 | 455.8 | (96.5 | ) | 552.3 | ||||||||||||||||||
| Effective tax rate |
28.7 | % | 32.4 | % | 32.4 | % | 32.0 | % | ||||||||||||||||||||
| Net income |
1,322.5 | (107.9 | ) | 85.4 | 1,345.0 | 952.2 | (221.2 | ) | 1,173.4 | |||||||||||||||||||
| Earnings per common share |
||||||||||||||||||||||||||||
| Basic |
$ | 2.55 | $ | (0.21 | ) | $ | 0.17 | $ | 2.59 | $ | 1.81 | $ | (0.43 | ) | $ | 2.24 | ||||||||||||
| Diluted |
$ | 2.43 | $ | (0.20 | ) | $ | 0.16 | $ | 2.47 | $ | 1.73 | $ | (0.40 | ) | $ | 2.13 | ||||||||||||
| Average common shares outstanding |
||||||||||||||||||||||||||||
| Basic |
511.2 | 511.2 | 511.2 | 511.2 | 515.4 | 515.4 | 515.4 | |||||||||||||||||||||
| Diluted |
544.4 | 544.4 | 544.4 | 544.4 | 550.7 | 550.7 | 550.7 | |||||||||||||||||||||
| (a) | See Table 3 “Supplemental Consolidated Income Statement Information-Other Items” for details. |
| Note: | Basic and diluted earnings per share for the “As Reported” and “Excluding Restructuring & Other Items” are computed independently for each quarter and the nine months presented. As a result of changes in shares outstanding during the year and rounding, the sum of the three quarters’ earnings per share may not necessarily equal the earnings per share for the nine months. In addition, the impact of “Restructuring” and “Other Items” in 2007 on the basic and diluted earnings per share may not necessarily equal the earnings per share if calculated independently as a result of rounding. |
Table 3
Colgate-Palmolive Company
Supplemental Consolidated Income Statement Information
Other Items
For the Three and Nine Months Ended September 30, 2007
(in Millions Except Per Share Amounts) (Unaudited)
| Three Months Ended September 30, 2007 | ||||||||||||||||||||
| Gain on Bleach Sale |
Hill's Product Voluntary Recall |
Tax Adjustments* |
SFAS 88 Pension Charges |
Total Other Items |
||||||||||||||||
| Net sales |
$ | — | $ | — | $ | — | $ | — | $ | — | ||||||||||
| Cost of sales |
— | — | — | — | — | |||||||||||||||
| Gross profit |
— | — | — | — | — | |||||||||||||||
| Selling, general and administrative expenses |
— | — | — | — | — | |||||||||||||||
| Other (income) expense, net |
— | — | — | 15.4 | 15.4 | |||||||||||||||
| Operating profit |
— | — | — | (15.4 | ) | (15.4 | ) | |||||||||||||
| Interest expense, net |
— | — | — | — | — | |||||||||||||||
| Income before income taxes |
— | — | — | (15.4 | ) | (15.4 | ) | |||||||||||||
| Provision for income taxes |
— | — | — | (5.4 | ) | (5.4 | ) | |||||||||||||
| Net income |
— | — | — | (10.0 | ) | (10.0 | ) | |||||||||||||
| Earnings per common share |
||||||||||||||||||||
| Basic |
$ | — | $ | — | $ | — | $ | (0.02 | ) | $ | (0.02 | ) | ||||||||
| Diluted |
$ | — | $ | — | $ | — | $ | (0.02 | ) | $ | (0.02 | ) | ||||||||
| Nine Months Ended September 30, 2007 | ||||||||||||||||||||
| Gain on Bleach Sale |
Hill's Product Voluntary Recall |
Tax Adjustments* |
SFAS 88 Pension Charges |
Total Other Items |
||||||||||||||||
| Net sales |
$ | — | $ | (2.1 | ) | $ | — | $ | — | $ | (2.1 | ) | ||||||||
| Cost of sales |
— | (1.1 | ) | — | — | (1.1 | ) | |||||||||||||
| Gross profit |
— | (1.0 | ) | — | — | (1.0 | ) | |||||||||||||
| Selling, general and administrative expenses |
— | — | — | — | — | |||||||||||||||
| Other (income) expense, net |
(48.6 | ) | 12.6 | — | 15.4 | (20.6 | ) | |||||||||||||
| Operating profit |
48.6 | (13.6 | ) | — | (15.4 | ) | 19.6 | |||||||||||||
| Interest expense, net |
— | — | — | — | — | |||||||||||||||
| Income before income taxes |
48.6 | (13.6 | ) | — | (15.4 | ) | 19.6 | |||||||||||||
| Provision for income taxes |
18.9 | (5.4 | ) | (73.9 | ) | (5.4 | ) | (65.8 | ) | |||||||||||
| Net income |
29.7 | (8.2 | ) | 73.9 | (10.0 | ) | 85.4 | |||||||||||||
| Earnings per common share |
||||||||||||||||||||
| Basic |
$ | 0.06 | $ | (0.02 | ) | $ | 0.15 | $ | (0.02 | ) | $ | 0.17 | ||||||||
| Diluted |
$ | 0.05 | $ | (0.01 | ) | $ | 0.14 | $ | (0.02 | ) | $ | 0.16 | ||||||||
| * | Reduction of tax loss carryforward valuation allowances in Brazil of $94.6, partially offset by tax provisions for the recapitalization of certain overseas subsidiaries. |
Table 4
Colgate-Palmolive Company
Condensed Consolidated Balance Sheets
As of September 30, 2007, December 31, 2006 and September 30, 2006
(Dollars in Millions) (Unaudited)
| September 30, 2007 |
December 31, 2006 |
September 30, 2006 |
||||||||||
| Cash and cash equivalents |
$ | 628.4 | $ | 489.5 | $ | 502.9 | ||||||
| Receivables, net |
1,758.0 | 1,523.2 | 1,446.3 | |||||||||
| Inventories |
1,167.0 | 1,008.4 | 1,001.6 | |||||||||
| Other current assets |
382.4 | 279.9 | 304.5 | |||||||||
| Property, plant and equipment, net |
2,831.7 | 2,696.1 | 2,526.4 | |||||||||
| Other assets, including goodwill and intangibles |
3,316.2 | 3,140.9 | 3,386.8 | |||||||||
| Total assets |
$ | 10,083.7 | $ | 9,138.0 | $ | 9,168.5 | ||||||
| Total debt |
3,608.2 | 3,671.2 | 3,577.9 | |||||||||
| Other current liabilities |
2,927.0 | 2,518.3 | 2,409.2 | |||||||||
| Other non-current liabilities |
1,526.4 | 1,537.6 | 1,546.8 | |||||||||
| Total liabilities |
8,061.6 | 7,727.1 | 7,533.9 | |||||||||
| Total shareholders’ equity |
2,022.1 | 1,410.9 | 1,634.6 | |||||||||
| Total liabilities and shareholders’ equity |
$ | 10,083.7 | $ | 9,138.0 | $ | 9,168.5 | ||||||
| Supplemental Balance Sheet Information |
||||||||||||
| Debt less cash and marketable securities* |
$ | 2,927.0 | $ | 3,170.2 | $ | 3,044.9 | ||||||
| Working capital % of sales |
2.4 | % | 2.3 | % | 2.6 | % | ||||||
| * | Marketable securities of $52.8, $11.5 and $30.1 as of September 30, 2007, December 31, 2006 and September 30, 2006, respectively, are included in Other current assets. |
Table 5
Colgate-Palmolive Company
Condensed Consolidated Statements of Cash Flows
For the Nine Months Ended September 30, 2007 and 2006
(Dollars in Millions) (Unaudited)
| 2007 | 2006 | |||||||
| Operating Activities |
||||||||
| Net income |
$ | 1,322.5 | $ | 952.2 | ||||
| Adjustments to reconcile net income to net cash provided by operations: |
|
|||||||
| Restructuring, net of cash |
(3.6 | ) | 187.6 | |||||
| Depreciation and amortization |
246.4 | 243.5 | ||||||
| Gain before tax on sale of non-core product lines |
(48.6 | ) | — | |||||
| Stock-based compensation expense |
93.1 | 91.7 | ||||||
| Deferred income taxes |
(60.2 | ) | (24.5 | ) | ||||
| Cash effects of changes in: |
| |||||||
| Receivables |
(167.0 | ) | (122.9 | ) | ||||
| Inventories |
(118.4 | ) | (128.9 | ) | ||||
| Accounts payable and other accruals |
364.8 | 122.8 | ||||||
| Other non-current assets and liabilities |
9.7 | 48.4 | ||||||
| Net cash provided by operations |
1,638.7 | 1,369.9 | ||||||
| Investing Activities |
||||||||
| Capital expenditures |
(327.1 | ) | (251.8 | ) | ||||
| Sale of property and non-core product lines |
106.0 | 2.9 | ||||||
| Payment for acquisitions, net of cash acquired |
(26.5 | ) | (200.0 | ) | ||||
| Other |
(56.0 | ) | (21.4 | ) | ||||
| Net cash used in investing activities |
(303.6 | ) | (470.3 | ) | ||||
| Financing Activities |
||||||||
| Principal payments on debt |
(1,635.9 | ) | (1,011.3 | ) | ||||
| Proceeds from issuance of debt |
1,530.4 | 1,116.7 | ||||||
| Dividends paid |
(550.4 | ) | (497.4 | ) | ||||
| Purchases of treasury shares |
(866.6 | ) | (601.3 | ) | ||||
| Proceeds from exercise of stock options and excess tax benefits |
313.7 | 258.5 | ||||||
| Net cash used in financing activities |
(1,208.8 | ) | (734.8 | ) | ||||
| Effect of exchange rate changes on Cash and cash equivalents |
12.6 | (2.6 | ) | |||||
| Net increase in Cash and cash equivalents |
138.9 | 162.2 | ||||||
| Cash and cash equivalents at beginning of period |
489.5 | 340.7 | ||||||
| Cash and cash equivalents at end of period |
$ | 628.4 | $ | 502.9 | ||||
| Supplemental Cash Flow Information |
||||||||
| Free cash flow before dividends (Net cash provided by operations less capital expenditures) |
||||||||
| Net cash provided by operations |
$ | 1,638.7 | $ | 1,369.9 | ||||
| Less: Capital expenditures |
(327.1 | ) | (251.8 | ) | ||||
| Free cash flow before dividends |
$ | 1,311.6 | $ | 1,118.1 | ||||
| Income taxes paid |
$ | 469.3 | $ | 497.9 | ||||
Table 6
Colgate-Palmolive Company
Segment Information
For the Three and Nine Months Ended September 30, 2007 and 2006
(Dollars in Millions) (Unaudited)
| Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
| 2007 | 2006 | 2007 | 2006 | |||||||||||||
| Net sales |
||||||||||||||||
| Oral, Personal and Home Care |
||||||||||||||||
| North America |
$ | 687.7 | $ | 668.1 | $ | 2,021.6 | $ | 1,933.1 | ||||||||
| Latin America |
893.7 | 769.3 | 2,544.9 | 2,203.1 | ||||||||||||
| Europe/South Pacific |
875.3 | 779.8 | 2,501.8 | 2,192.7 | ||||||||||||
| Greater Asia/Africa |
607.2 | 512.5 | 1,726.0 | 1,489.6 | ||||||||||||
| Total Oral, Personal and Home Care |
$ | 3,063.9 | $ | 2,729.7 | $ | 8,794.3 | $ | 7,818.5 | ||||||||
| Pet Nutrition |
464.3 | 414.0 | 1,353.2 | 1,210.1 | ||||||||||||
| Total Net sales |
$ | 3,528.2 | $ | 3,143.7 | $ | 10,147.5 | $ | 9,028.6 | ||||||||
| Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
| 2007 | 2006 | 2007 | 2006 | |||||||||||||
| Operating profit |
||||||||||||||||
| Oral, Personal and Home Care |
||||||||||||||||
| North America |
$ | 171.0 | $ | 143.5 | $ | 484.8 | $ | 418.7 | ||||||||
| Latin America |
250.2 | 220.8 | 742.4 | 651.9 | ||||||||||||
| Europe/South Pacific |
199.9 | 179.5 | 565.7 | 495.1 | ||||||||||||
| Greater Asia/Africa |
90.8 | 65.9 | 259.2 | 199.3 | ||||||||||||
| Total Oral, Personal and Home Care |
$ | 711.9 | $ | 609.7 | $ | 2,052.1 | $ | 1,765.0 | ||||||||
| Pet Nutrition |
116.9 | 106.7 | 354.5 | 318.4 | ||||||||||||
| Corporate |
(160.0 | ) | (167.0 | ) | (429.1 | ) | (555.6 | ) | ||||||||
| Total Operating profit |
$ | 668.8 | $ | 549.4 | $ | 1,977.5 | $ | 1,527.8 | ||||||||
The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes. Corporate operations include research and development costs, unallocated overhead costs, stock-based compensation related to stock options and restricted stock awards, restructuring and related implementation costs, SFAS 88 pension charges and gains and losses on sales of non-core brands and assets.
For the three months ended September 30, 2007 and 2006, Corporate operating expenses include $51.1 and $84.0 of charges related to the Company’s 2004 Restructuring Program, respectively. For the nine months ended September 30, 2007 and 2006, Corporate operating expenses include $152.4 and $317.7 of charges related to the Company’s 2004 Restructuring Program, respectively. Additionally, Corporate operating expenses for the three and nine months ended September 30, 2007 were increased by SFAS 88 pension charges of $15.4. For the nine months ended September 30, 2007, Corporate operating expenses were reduced by a $48.6 gain related to the sale of the Company's household bleach business in Latin America.
As a result of a limited voluntary recall of Hill's product in March 2007, Pet Nutrition Net sales for the nine months ended September 30, 2007 were reduced by $2.1 and Corporate operating expenses increased by $13.6.
Table 7
Colgate-Palmolive Company
Geographic Sales Analysis
Percentage Changes - Third Quarter 2007 vs 2006
September 30, 2007
(Unaudited)
| COMPONENTS OF SALES CHANGE THIRD QUARTER |
COMPONENTS OF SALES CHANGE NINE MONTHS |
|||||||||||||||||||||||||||||||||||||
| Region |
3rd Qtr Sales Change As Reported |
3rd Qtr Sales Change Ex-Divestment |
Ex-Divested Volume |
Pricing Coupons Consumer & Trade Incentives |
Exchange | 9 Months Sales Change As Reported |
9 Months Sales Change Ex-Divestment |
Ex-Divested Volume |
Pricing Coupons Consumer & Trade Incentives |
Exchange | ||||||||||||||||||||||||||||
| Total Company |
12.0 | % | 13.0 | % | 6.5 | % | 1.0 | % | 5.5 | % | 12.5 | % | 13.0 | % | 7.5 | % | 1.0 | % | 4.5 | % | ||||||||||||||||||
| Europe/South Pacific |
12.0 | % | 12.0 | % | 4.5 | % | (2.0 | )% | 9.5 | % | 14.0 | % | 14.0 | % | 6.0 | % | (1.5 | )% | 9.5 | % | ||||||||||||||||||
| Latin America |
16.0 | % | 18.0 | % | 9.5 | % | 3.0 | % | 5.5 | % | 15.5 | % | 17.0 | % | 12.0 | % | 1.5 | % | 3.5 | % | ||||||||||||||||||
| Greater Asia/Africa |
18.5 | % | 18.5 | % | 9.5 | % | 1.0 | % | 8.0 | % | 16.0 | % | 16.0 | % | 9.0 | % | 1.5 | % | 5.5 | % | ||||||||||||||||||
| Total International |
15.5 | % | 16.0 | % | 7.5 | % | 1.0 | % | 7.5 | % | 15.0 | % | 15.5 | % | 9.0 | % | 0.5 | % | 6.0 | % | ||||||||||||||||||
| North America |
3.0 | % | 4.5 | % | 3.0 | % | 0.5 | % | 1.0 | % | 4.5 | % | 6.0 | % | 5.5 | % | 0.5 | % | 0.0 | % | ||||||||||||||||||
| Total CP Products |
12.0 | % | 13.0 | % | 6.5 | % | 0.5 | % | 6.0 | % | 12.5 | % | 13.0 | % | 8.0 | % | 0.5 | % | 4.5 | % | ||||||||||||||||||
| Hill's |
12.0 | % | 12.0 | % | 5.0 | % | 4.0 | % | 3.0 | % | 12.0 | % | 12.0 | % | 5.0 | % | 4.5 | % | 2.5 | % | ||||||||||||||||||